Epidemiology of adult separation anxiety disorder in the Kingdom of Saudi Arabia: results from the Saudi National Mental Health Survey

沙特阿拉伯王国成人分离焦虑症的流行病学:来自沙特国家心理健康调查的结果

阅读:1

Abstract

PURPOSE: Adult separation anxiety disorder (ASAD) is thought to be prevalent and debilitating, yet many aspects of its epidemiology remain unclear. We aimed to investigate prevalence, course, correlates, comorbidity, impairment, and treatment of ASAD in Saudi Arabia. METHODS: The study analyzed a subset of 1793 participants from the Saudi National Mental Health Survey; a nationally representative household sample of Saudi citizens. The survey used the CIDI 3.0 to produce prevalence estimates of ASAD and other common DSM-IV mental disorders. Cross tabulations, survival analysis and logistic regression were used to analyse the data. RESULTS: The lifetime and 12-month prevalence of ASAD were 7.6% and 3.8%, respectively. Over half (51.7%) of participants with lifetime ASAD had onset in adulthood, and 50.5% of those with lifetime ASAD also had 12-month ASAD. Lifetime ASAD was significantly associated with being female (OR = 2.1), not being married (ORs = 2.2-3.2), having low education (OR = 0.4), and maladaptive family functioning (ORs = 3.6-6.7). Primary lifetime ASAD was a strong predictor of subsequent other mental disorders (ORs = 1.1-6.5). Further, mood, impulse, and substance use disorders were significantly associated with subsequent first onset of ASAD (ORs = 2.15-3.0). ASAD was severely impairing in the presence (59.0%) or absence (56.2%) of 12-month comorbidity. Among those with lifetime ASAD, only 26.1% reported treatment for a mental health condition. CONCLUSION: ASAD is prevalent, with a persistent course and associated impairment, as well as substantial comorbidity and limited treatment in Saudi Arabia. Increasing awareness, early diagnosis, and treatment of ASAD may help reduce its burden.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。